Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis (Q40269148)

19 September 2017

title

Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis (English)

1 reference

19 September 2017

8

Vincent Bours

0 references

Marie-Paule Merville

7

object named as

Marie-Paule Merville

0 references

Nathalie Franchimont

3

object named as

Nathalie Franchimont

0 references

author name string

Biserka Relic

1

1 reference

19 September 2017

Valérie Benoit

2

1 reference

19 September 2017

Nathalie Franchimont

3

1 reference

19 September 2017

Marie-Joelle Kaiser

4

1 reference

19 September 2017

Jean-Philippe Hauzeur

5

1 reference

19 September 2017

Philippe Gillet

6

1 reference

19 September 2017

Marie-Paule Merville

7

1 reference

19 September 2017

Michel G Malaise

9

1 reference

19 September 2017

language of work or name

English

0 references

publication date

9 June 2006

1 reference

Journal of Biological Chemistry

19 September 2017

published in

1 reference

19 September 2017

volume

281

1 reference

19 September 2017

issue

32

1 reference

19 September 2017

page(s)

22597-22604

1 reference

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Peroxisome proliferator-activated receptor γ in diabetes and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

The role of apoptosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Apoptosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Apoptosis in rheumatoid arthritis: friend or foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Degradation of CFTR by the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix association

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Substrate targeting in the ubiquitin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

c-Fos Proto-Oncoprotein Is Degraded by the Proteasome Independently of Its Own Ubiquitinylation In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Functional changes in rheumatoid fibroblast-like synovial cells through activation of peroxisome proliferator-activated receptor gamma-mediated signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Mechanical stretching inhibits adipocyte differentiation of 3T3-L1 cells: the molecular mechanism and pharmacological regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Pro-inflammatory properties for thiazolidinediones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512807200

21 January 2018

Identifiers

DOI

10.1074/JBC.M512807200

1 reference

19 September 2017

1 reference